… Unlike lenalidomide, the role of bortezomib in the consolidation or maintenance … meta-analysis
of randomized controlled trials (RCTs) to examine the efficacy and safety of bortezomib-…

… patients with myeloma enrolled in randomized clinical trials (… in the UPFRONT study –
bortezomib/dexamethasone [0.3% (… of treatment in patients with multiple myeloma on clinical trials. …

… of combined data from randomized controlled trials (RCTs) will … The aim of this systematic
review and meta-analysis was to … number of clinical trials contributing to this meta-analysis is …

… Bortezomib, lenalidomide and dexamethasone vs. … in patients (Pts) with previously
untreated multiple myeloma … Because this study is a systematic review, and not a meta-analysis…

… Systematic search was performed up to August 2021 to identify randomised controlled trials
… in relapsed/refractory and newly diagnosed myeloma (RRMM and NDMM, respectively). …

… used a systematic review to identify randomized controlled trials (… of the randomized phase
III trial SWOG S0777: bortezomib, … in patients (Pts) with previously untreated multiple myeloma …

… VMP and Rd in large randomised controlled trials (RCTs). … up of the randomized phase III
trial SWOG S0777: bortezomib, … in patients (Pts) with previously untreated multiple myeloma …

… 3, randomized controlled trial (RCT)—found no significant difference in progression-free
survival (PFS) between previously-untreated patients … (KRd) versus bortezomib/lenalidomide/…

… Items for Systematic Reviews and Meta-analysis (PRISMA) … bortezomib versus placebo
plus bortezomib 286 Siltuximab plus bortezomib : 64 (range : 36- 82) ; placebo plus bortezomib : …

… We did a systematic review of randomised controlled trials that reported SPM in patients …
used fixed effects for stratified meta-analysis of multiple myeloma studies. Risk of bias was …